KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Nov 06, 2025 - 3:59PM >>  ABB India 5240.1  [ -0.31% ]  ACC 1831.5  [ -2.02% ]  Ambuja Cements 567.3  [ -1.74% ]  Asian Paints Ltd. 2486.6  [ -1.02% ]  Axis Bank Ltd. 1226.9  [ -0.59% ]  Bajaj Auto 8747.15  [ -1.99% ]  Bank of Baroda 288.1  [ -1.03% ]  Bharti Airtel 2112.9  [ 1.89% ]  Bharat Heavy Ele 267.2  [ 0.83% ]  Bharat Petroleum 372.95  [ 1.52% ]  Britannia Ind. 5886.7  [ 1.12% ]  Cipla 1503.55  [ -0.53% ]  Coal India 377.7  [ -2.79% ]  Colgate Palm 2190.45  [ -0.46% ]  Dabur India 517  [ 2.71% ]  DLF Ltd. 774.05  [ -0.36% ]  Dr. Reddy's Labs 1200.8  [ 0.36% ]  GAIL (India) 181.6  [ -0.87% ]  Grasim Inds. 2880.7  [ -0.81% ]  HCL Technologies 1528.7  [ -1.05% ]  HDFC Bank 985.1  [ -0.75% ]  Hero MotoCorp 5309.2  [ -4.11% ]  Hindustan Unilever L 2446.05  [ -0.58% ]  Hindalco Indus. 830.95  [ -1.80% ]  ICICI Bank 1336.6  [ -0.67% ]  Indian Hotels Co 743.45  [ -0.48% ]  IndusInd Bank 789.5  [ -0.95% ]  Infosys L 1468  [ -1.17% ]  ITC Ltd. 408.6  [ -1.29% ]  Jindal Steel 1079.4  [ 0.33% ]  Kotak Mahindra Bank 2095.8  [ -0.83% ]  L&T 3921.2  [ -1.48% ]  Lupin Ltd. 1998.15  [ 0.62% ]  Mahi. & Mahi 3581.55  [ 0.93% ]  Maruti Suzuki India 15370.45  [ -1.76% ]  MTNL 41.88  [ -1.53% ]  Nestle India 1264.75  [ -0.28% ]  NIIT Ltd. 103.15  [ -0.72% ]  NMDC Ltd. 74.29  [ -2.21% ]  NTPC 330.7  [ -1.34% ]  ONGC 252.4  [ -1.98% ]  Punj. NationlBak 123.25  [ -0.16% ]  Power Grid Corpo 279  [ -3.13% ]  Reliance Inds. 1471.85  [ -0.84% ]  SBI 957.05  [ 0.72% ]  Vedanta 508.05  [ -0.94% ]  Shipping Corpn. 250.15  [ -2.65% ]  Sun Pharma. 1692.75  [ -0.85% ]  Tata Chemicals 892.45  [ 1.97% ]  Tata Consumer Produc 1179.2  [ -1.69% ]  Tata Motors Passenge 406.5  [ -2.53% ]  Tata Steel 179.25  [ -1.86% ]  Tata Power Co. 400.75  [ -1.87% ]  Tata Consultancy 2989.8  [ -0.87% ]  Tech Mahindra 1408.8  [ -0.75% ]  UltraTech Cement 11815.55  [ -1.15% ]  United Spirits 1451  [ 0.22% ]  Wipro 238.05  [ -0.98% ]  Zee Entertainment En 101.95  [ 1.29% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

SHANMUGA HOSPITAL LTD.

06 November 2025 | 04:01

Industry >> Hospitals & Medical Services

Select Another Company

ISIN No INE0TD301017 BSE Code / NSE Code 544365 / SHANMUGA Book Value (Rs.) 17.15 Face Value 10.00
Bookclosure 52Week High 54 EPS 3.09 P/E 14.69
Market Cap. 61.80 Cr. 52Week Low 31 P/BV / Div Yield (%) 2.65 / 0.00 Market Lot 2,000.00
Security Type Other

NOTES TO ACCOUNTS

You can view the entire text of Notes to accounts of the company for the latest year
Year End :2025-03 

a) Provisions and Contingent Liabilities:

A provision is recognised if, as a result of past event, the Company has a present legal
obligation that can be estimated reliably and it is probable that an outflow of economic benefit
will be required to settle the obligation. Provisions are determined by the best estimate
of outflow of economic benefits required to settle the obligation at the reporting date. Where no
reliable estimate can be made, a disclosure is made as contingent liability.

A disclosure for a contingent liability is also made when there is a possible obligation or a
present obligation that may, but probably will not, require an outflow of resources. Where there
is possible obligation or present obligation in respect of which the likelihood of outflow of
resources is remote, no provision or disclosure is made.

m) . Earnings Per Share:

Basic Earnings per share is computed by dividing the net profit after tax by the weighted
average number of equity shares outstanding during the period. Diluted earnings per share is
computed by dividing the net profit after tax by the weighted average number of shares
considered for deriving basic earnings per share and also the weighted average number of
equity shares that could have been issued upon conversion of all dilutive potential equity
shares. The diluted potential equity shares are adjusted for the proceeds receivable had the
shares been actually issued at fair value which is the average market value of the outstanding
shares. Dilutive potential equity shares are deemed converted as at the beginning of the
period, unless issued at a later date. Dilutive potential equity shares are determined
independently for each period presented.

n) Cash and Bank Balances:

Cash and cash equivalents comprises Cash-in-hand, Current Accounts, Fixed Deposits with
banks. Cash equivalents are short-term balances (with an original maturity of three months or
less from the date of acquisition), highly liquid investments that are readily convertible into
known amounts of cash and which are subject to insignificant risk of changes in value. Other
Bank Balances are short-term balance (with original maturity is more than three months but
less than twelve months).

o) . Cash Flow Statement:

Cash flows are reported using indirect method, whereby net profit/loss before tax is adjusted
for the effects of transactions of a non-cash nature, any deferrals or accruals of past or future
operating cash receipts or payments and item of income or expenses associated with
investing or financing cash flows. The cash flows from operating, investing and financing
activities of the Company are segregated.

P) . Segment Reporting:

The Operations of the company are in the nature of sale of medicines and services to the
patients. Since the service nature includes medicines and consumables utilized and forming
part of the same treatment to the patients, bifurcation of expenses, assets may not be
practicable and separable for the operations, hence the combined nature of treatment
through service and sale can only be regarded as a single segment. Since the company is
operating in a segment, hence segment reporting is not applicable.

Q) . Investments:

Investments, which are readily realizable and intended to be held for not more than one year
from the date on which such investments are made, are classified as current investments. All
other investments are classified as long-term investments.

Terms/Rights attached to Equity Shares:

(a) The company has only one class of Equity Shares having a par value of f 10/- per share.
Each holder of Equity share is entitled to one vote per share. In the event of liquidation of the
Company, the holders of equity share will be entitled to receive remaining Assets of the
Company, after distribution of all preferential amounts. The distribution will be in proportion to
the number of equity shares held by the Share holders.

(b) The equity shares are not repayable except in the case of a buy back, reduction of capital
or winding up in terms of the provisions of the Companies Act, 2013.

(c) Every member of the company holding equity shares has a right to attend the General
Meeting of the Company and has a right to speak and on a show of hands, has one vote if he is
present in person and on a poll shall have the right to vote in proportion to his share of the
paid-up capital of the company.

d) The rights, preferences and restrictions attaching to each class of shares:

The Company has only one class of shares and all shareholder have equal rights and there are
no restriction.

2 Proposed Dividend Details:

The Company has not declared dividend during the period under review.

3 No issue of securities were made for any specificpurpose by the Company duringthe
reporting year.

4 The Company has not made borrowings from banks and financial institutions for any
specific purposes during the year

5 The assets other than Property, Plant and Equipment, Intangible Assets and non-current
investments have value on realization in the ordinary course of business equal to the
amount at which they are stated

6Details of Benami Property Held:

There are no proceedings initiated or pending against the Company for holding any
benami property under the Benami Transactions (Prohibition) Act, 1988 (45 of 1988).

7 The Company has made borrowings from the banks on the basis of security of current
assets, and the statements of current assets as required to be filed by the Company with
any the banks or financial institutions are done periodically.

8 Wilful Defaulter:

The company is not declared as wilful defaulter by any bank or financial institution or other
lender.

9 Relationship with Struck off Companies:

The Company has not entered into any transactions with companies struck off
undersection 248 of the Companies Act, 2013.

10 Registration of Charges or Satisfaction with Registrar of Companies:

The Company has no charge which is yet to be registered with Registrar of Companies
beyond the statutory period .

11 Compliance with Number of Layers of Companies:

The Company has no subsidiaries hence layers prescribed under clause (87) of section2 of
the Act read with Companies (Restriction on number of Layers) Rules,2017 are not
applicable.

12 Compliance with Approved Scheme(s)of Arrangements:

No Scheme of Arrangements has been approved by the Competent Authority in terms of
sections 230 to 237 of the Companies Act, 2013.

13. Utilisation of Borrowed Funds and Share Premium:

A. The company has not advanced or loaned or invested funds (either borrowed funds or
share premium or any other sources or kind of funds) to any other person(s) or
entity(ies), including foreign entities (Intermediaries) with the understanding (whether
recorded in writing or otherwise) that the Intermediary shall

(i) directly or indirectly lend or invest in other persons or entities identified in any manner
whatsoever by or on behalf of the company (Ultimate Beneficiaries) or

(ii) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

B. The Company has not received any fund from any person(s) or entity(ies), including
foreign entities (Funding Party) with the understanding (whether recorded in

writing or otherwise) that the company shall

(i) directly or indirectly lend or invest in other persons or entities identified in any manner
whatsoever by or on behalf of the Funding Party (Ultimate Beneficiaries) or

(ii) provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

14. Corporate Social Responsibility:

As per provisions of Section 135 of the Companies Act, 2013, the applicability towards CSR

has commenced from the financial year 2022-23 onwards.Our Company

has constituted the Corporate Social Responsibility Committee under sub-section (1) of

Section 135 of Companies Act, 2013. As part of its initiatives under "Corporate

Social Responsibility (CSR), our Company has undertaken projects in the areas of

Healthcare, Livelihood and Education. These projects are in accordance with Schedule

VII read with Section 135 (2) of the Companies Act, 2013.

19 Undisclosed Income:

There are no transactions that were not recorded in the books of account,and which has
been surrendered or disclosed as income during the year inthe tax assessments under the
Income Tax Act, 1961 (43 of 1961).

There is no previously unrecorded income and related assets have been recorded in the
books of account during the year.

20 Details of Crypto Currency or Virtual Currency:

The Company has not traded or invested in Crypto currency or Virtual Currency during the
financial year.

21 Dues to Micro, Small and Medium Enterprise (MSME):

The dues towards micro, small and medium enterprises have been disclosed in the
schedules to balance sheet.

Note:

Mr Veera Pratap Reddy Gandaluru resgined as Company secretary on 24.03.2025 and Mrs K
Anjana Maragatham is appointed as Company secretary cum compliance officer on 31.3.25

25 Employee Benefit (Incurred in India):

Gratuity - The Present value of obligation is determined based on actuarial valuation using
the Projected Unit Credit Method and is unfunded. This method considers each period of
service as giving rise to an additional unit of benefit entitlement and measures each unit
separately to build up the final obligation.

Interest Cost: It is the increase in the Plan liability over the accounting period resulting from
the operation of the actuarial assumption of the interest rate.

Current Service Cost: is the discounted present value of the benefits from the Plan's benefit
formula attributable to the services rendered by employees during the accounting period.
Actuarial Gain or Loss: occurs when the experience of the Plan differs from that anticipated
from the actuarial assumptions. It could also occur due to changes made in the actuarial
assumptions.

The estimates of rate of escalation in salary considered in actuarial valuation, take into

account inflation, seniority, promotion and other relevant factors including supply

26 Cash Flow Statement:

• The amount of cash and bank balances held by the enterprise as at March 31, 2025 was
Rs.12,58,93,416.79/- that are available for use by Company.

• Company does not have undrawn borrowing facilities that may be available for future
operating activities.

• The Company has appropriate amount of Cash Flows that are required to maintain
operating capacity.

• Company is investingadequately in the maintenance of its operatingcapacity.

• There are no non cash transactions happened in investing and financing activities to be
excluded from Cash Flow Statement.

27. Changes in Accounting Estimates:

There are no changes in Accounting Estimates made by the Company for the period ended

31st Mar 2025.

28. Changes in Accounting Policies:

There are no changes in Accounting Policy made by the Company for the period ended 31st

Mar 2025.

29. Disclosures on Property, Plant and Equipment and Intangible Assets:

I. Property, Plant and Equipment

• There is no restriction on the title of Property, Plant and Equipment, subject to only those
which are under hypothication/ charge.

• Company has no contractual commitments for the acquisition of Property, Plant &
Equipment.

• Company has no Impairment loss during the period for Property, Plant & Equipment.

• Assets are periodically checked for active usage and those which are retired are written
off.

• There are no temporarily idle property, plant and equipment.

• Intangible asset is amortised as per Schedule II

• The carrying amount and remaining amortization period of any individual intangible
asset are not material to the financial statements of the enterprise as a whole.

• There are no amounts of intangible assets whose title is restricted and the carrying
amounts of intangible assets pledged as security for liabilities.

30. Investments:

I. Profits and Losses with Regard to Investments have been Disclosed as under:

a) Profits and losses on disposal of current investments

b) Profits and losses on changes in the carrying amount of current investments

c) Profits and losses on disposal of long-term investments

d) Profits and losses on changes in the carrying amount of long- term investments

31 Segment Reporting:

The Operations of the company are in the nature of sale of medicines and services to the
patients. Since the service nature includes medicines and consumables utilized and
forming part of the same treatment to the patients, bifurcation of expenses, assets may not
be practicable and separable for the operations, hence the combined nature of treatment
through service and sale can only be regarded as a single segment. Since the company is
operating in a segment, hence segment reporting is not applicable.

32 Balance shown under head Sundry debtors, creditors and advances are subject to
confirmation.

33 Previous year's figures have been regrouped / reclassified wherever necessary to
correspond with current year's classification.

As per our report of even date attached

_ For and on behalf of the Board of Directors

For P P N And Company

Chartered Accountants of SHANMUGASp|TAL UM|TED

(formerly known as Shanmuga Hospital Private Limited)

Firm's Reg. No: 013623S

Peer Review Certificate No. 013578 Sd/- Sd/- Sd/-

Sd/- Dr. P. S. Panneerselvam Dr. P. Prabu Sankar Mrs. Panneerselvam Jayalakshmi

R.Rajaram Managing Director Director cum CEO Director

Partner DIN: 08772887 DIN: 08772888 DIN: 10692764

M.No: 238452 .

UDIN: 25238452BMHSUK7930 Sd/- Sd/-

Mr. Karthick CS Kannan Anjana Maragatham

Salem Chief Financial Officer Company Secretary

28-05-2025 PAN: FB******6P M No: A70080